Allen David, Giannopoulos Konstantinos, Gray Ian, Gregson Norman, Makowska Anna, Pritchard Jane, Hughes Richard A C
Department of Clinical Neurosciences, Guy's Campus, Guy's, King's and St. Thomas' School of Medicine, King's College, Denmark Hill, London SE5 9RS, UK.
J Peripher Nerv Syst. 2005 Jun;10(2):174-80. doi: 10.1111/j.1085-9489.2005.0010207.x.
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an acquired disorder of the peripheral nervous system with a probable auto-immune pathogenesis. The nature of the responsible autoantigens is unclear in most patients. We used the Western immunoblot technique to seek antibodies to peripheral nerve protein antigens. Sera from eight of 32 (25%) CIDP patients, 12 of 37 (32%) Guillain-Barré syndrome (GBS) patients, zero of 30 (0%) chronic idiopathic axonal polyneuropathy patients and two of 39 (5%) healthy control subjects contained anti-peripheral nerve protein antibodies. The frequency of such antibodies was significantly greater in both CIDP (p = 0.04) and GBS (p = 0.003) patients than in normal control subjects. For CIDP patients, there were non-significant trends for antibodies to be more common in females and in those who responded to treatment with either intravenous immunoglobulin or plasma exchange. The commonest antibodies were directed against a band at 28 kDa, resembling that labelled by a monoclonal antibody against myelin protein zero (P0). Six CIDP and seven GBS patients' sera reacted with this band. These results support the view that antibodies to myelin proteins, and especially P0, are present in the serum of some patients with CIDP and GBS.
慢性炎症性脱髓鞘性多发性神经根神经病(CIDP)是一种获得性周围神经系统疾病,可能由自身免疫发病机制引起。在大多数患者中,致病自身抗原的性质尚不清楚。我们使用蛋白质免疫印迹技术寻找针对周围神经蛋白抗原的抗体。32例CIDP患者中有8例(25%)、37例吉兰-巴雷综合征(GBS)患者中有12例(32%)、30例慢性特发性轴索性多发性神经病患者中无(0%)、39例健康对照者中有2例(5%)的血清含有抗周围神经蛋白抗体。在CIDP患者(p = 0.04)和GBS患者(p = 0.003)中,此类抗体的频率均显著高于正常对照者。对于CIDP患者,抗体在女性以及对静脉注射免疫球蛋白或血浆置换治疗有反应的患者中更常见,但差异无统计学意义。最常见的抗体针对一条28 kDa的条带,类似于抗髓鞘蛋白零(P0)单克隆抗体标记的条带。6例CIDP患者和7例GBS患者的血清与该条带发生反应。这些结果支持这样一种观点,即某些CIDP和GBS患者血清中存在针对髓鞘蛋白尤其是P0的抗体。